Medication against alopecia is finally a reality, the FDA in the last few hours has given the green light, it is used to regrow hair.
It seemed like a distant process yet science gallops day by day and in the last few hours the news has arrived that it will certainly change the lives of many people who may experience the problem with real discomfort. Even Jada Pinkett Smith, the wife of Oscar-winning actor Will Smith has confessed several times to living the problem of her that she is now there for all to see in a very tragic way.
In any case, as reported by the Press in the past few hours, approval has arrived from the Food and Drug Administration or the FDA for the specific drug for these patients even if as with everything you must always have the time to find out how it evolves.
But let’s get to the heart of the matter and try to understand well what it is and how we got to this point, the path was certainly not easy.
Alopecia drug, here are its benefits
Medication against alopecia this time it is really a reality, after the studies carried out it was the FDA that approved the sale exclusively for people suffering from this problem.
Still according to what the Press reports, the form of alopecia for which the FDA has approved this new drug is not yet completely clear, it seems that despite the problem affects about 2% of the population including children, it seems that the causes are not yet known. The only certain thing is that it is an autoimmune disease in which: “The lymphocytes, the cells of the immune system, recognize the hair bulbs as foreign and attack them.”
In any case, the promises seem to be the best, according to the studies conducted in fact it seems that the difference between before and after is relevant, within a few years we go from being completely bald to having thick hair.
The oral drug in question is Baricitinib, manufactured by the American company Eli Lilly: “We know that there is a certain familiarity among those who suffer from it and that, in some cases, it can manifest itself in particularly stressful moments in life “, admitted dermatologist Marcella Ribuffo, president of LILT Rome.
At present, the drug in question has been tested in two studies involving 1,200 patients with severe alopecia areata.
(The information presented here relates to scientific studies published in medical journals. It should not replace the advice of a doctor or specialist, and should not be considered for formulating treatments or diagnoses).